Evidence map›Paper›PMID 42707655›Full record

ArticleRisk management and healthcare policy2026

Risk Governance of Payment Exceptions Under China's DRG/DIP Reform: A Structured Policy-Text Analysis of Special Case Negotiation Rules.

Kedi Sun

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kedi SunSchool of Graduate Studies, Lingnan University, Hong Kong, SAR, People's Republic of China.ORCID 0009-0009-0058-2905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Under China's diagnosis-related group/diagnosis-intervention packet (DRG/DIP) payment reform, special case negotiation addresses clinically atypical cases that do not fit standard case-based payment rules but may also create payment misfit, fund leakage, discretionary review, delay, and accountability risks. This study examined whether policies translate these risks into enforceable governance rules. Methods: A structured policy-text analysis examined 20 documents within one provincial policy chain: one national document, one provincial document, and 18 municipal documents covering all prefecture-level jurisdictions in the province. The municipal documents constituted a complete census within the selected province rather than a nationwide sample of Chinese provinces. A 30-node, five-domain framework used a 0-1-2 scale. Two coders worked independently, and final analyses used adjudicated scores. Results: Inter-coder agreement was 95.0% (Cohen's kappa, 0.899). Domain scores were highest for payment misfit risk control (0.797), discretion and capture risk control (0.786), and administrative burden and delay risk control (0.767), and lowest for accountability and equity risk control (0.512). Applicable scope, volume or proportion cap, and submission or review cycle were universally enforceable. The weakest or least consistently enforceable nodes concerned cross-area or fund responsibility, appeal or reconsideration, processing time limits, and special diseases, infectious diseases, or rare diseases. Vertical attenuation was highest for cross-area or fund responsibility (72.2%) and for processing time limits and special diseases, infectious diseases, or rare diseases (both 55.6%). Municipal documents formed balanced, boundary-heavy, procedure-heavy, and low-formalisation configurations. Conclusion: Special case negotiation requires a minimum risk-governance package-a minimum set of enforceable procedural safeguards-combining eligibility boundaries, traceable review, appeal routes, and clear accountability. The analysis evaluates formal policy design rather than implementation outcomes. Functionally, the framework may inform risk audits of outlier, high-cost, new-technology, and other payment-exception mechanisms in DRG or other case-based payment systems internationally.

Indexed as

accountabilityDIPDRGenforceabilityhealth policyprocedural safeguardsrisk governancespecial case negotiation

Identifiers

PMID42707655
PMCPMC13549295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.